14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:NMTR
Delisted

9 Meters Biopharma, Inc. Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0722
+0 (+0%)
At Close: Nov 20, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0722 $0.0722 Monday, 20th Nov 2023 NMTR stock ended at $0.0722. During the day the stock fluctuated 0% from a day low at $0.0722 to a day high of $0.0722.
90 days $0.0722 $0.0722
52 weeks $0.0150 $2.79

Historical 9 Meters Biopharma, Inc. prices

Date Open High Low Close Volume
Nov 20, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 17, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 16, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 15, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 14, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 13, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 10, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 09, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 08, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 07, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 06, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 03, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 02, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Nov 01, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 31, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 30, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 27, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 26, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 25, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 24, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 23, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 20, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 19, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 18, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Oct 17, 2023 $0.0722 $0.0722 $0.0722 $0.0722 0
Click to get the best stock tips daily for free!

About 9 Meters Biopharma, Inc.

9 Meters Biopharma. 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide... NMTR Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT